These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The generic drug approval process. Rheinstein PH Am Fam Physician; 1993 Dec; 48(8):1357-60. PubMed ID: 8249762 [No Abstract] [Full Text] [Related]
3. Generic Drugs. Med Lett Drugs Ther; 2002 Oct; 44(1141):89-90. PubMed ID: 12405134 [No Abstract] [Full Text] [Related]
4. The Food and Drug Administration and patent law at a crossroads: the listing of polymorph patents as a barrier to generic drug entry. Srivastava D Food Drug Law J; 2004; 59(2):339-54. PubMed ID: 15298015 [No Abstract] [Full Text] [Related]
5. Initial responses to recommendations of the Blue Ribbon Committee on Generic Medicines. Heller WM Am J Hosp Pharm; 1993 Feb; 50(2):318-22. PubMed ID: 8480792 [No Abstract] [Full Text] [Related]
6. United States Food and Drug Administration requirements for approval of generic drug products. Meyer MC J Clin Psychiatry; 2001; 62 Suppl 5():4-9; discussion 23-4. PubMed ID: 11305846 [TBL] [Abstract][Full Text] [Related]
8. Generic and alternative brand-name pharmaceutical equivalents: select with caution. Hendeles L; Hochhaus G; Kazerounian S Am J Hosp Pharm; 1993 Feb; 50(2):323-9. PubMed ID: 8480793 [No Abstract] [Full Text] [Related]
9. Generic substitution: issues for problematic drugs. Henderson JD; Esham RH South Med J; 2001 Jan; 94(1):16-21. PubMed ID: 11213935 [TBL] [Abstract][Full Text] [Related]
10. Indian company seeks US approval for generic AIDS drugs. Nature; 2004 Aug; 430(7001):716. PubMed ID: 15306779 [No Abstract] [Full Text] [Related]
11. Managed care implications of the approval of generic or over-the-counter nonsedating antihistamines. Giaquinta D Manag Care Interface; 2002 Jun; 15(6):31-4. PubMed ID: 12087604 [No Abstract] [Full Text] [Related]
12. Comparison of the bioequivalence of generic versus branded clozapine. Ereshefsky L; Glazer WM J Clin Psychiatry; 2001; 62 Suppl 5():25-7. PubMed ID: 11305845 [No Abstract] [Full Text] [Related]
13. Generic drug product equivalence: current status. Meyer MC Am J Manag Care; 1998 Aug; 4(8):1183-9; quiz 1190-2. PubMed ID: 10182892 [TBL] [Abstract][Full Text] [Related]
14. Generic drug substitution. Rogowski A; Lemay V Med Health R I; 2001 Jul; 84(7):241-4. PubMed ID: 11482281 [No Abstract] [Full Text] [Related]
15. The Hatch-Waxman Act: balancing competing interests or survival of the fittest? Behrendt KE Food Drug Law J; 2002; 57(2):247-71. PubMed ID: 12436990 [No Abstract] [Full Text] [Related]
17. Substitution of NTI drugs: physicians must maintain control. Todd JS J Med Assoc Ga; 1997 Apr; 86(2):121-3. PubMed ID: 9114660 [No Abstract] [Full Text] [Related]
18. Generic drugs. Save money--but is there a cost? Roberts SS Diabetes Forecast; 2002 Nov; 55(11):51-3. PubMed ID: 14768605 [No Abstract] [Full Text] [Related]
19. Current issues in the pioneer versus generic drug wars. Safir PO Food Drug Law J; 1995; 50(2):335-9. PubMed ID: 10343002 [No Abstract] [Full Text] [Related]